SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.

Journal: Cell Stem Cell

Published: 2020-09-18

DOI: 10.1016/j.stem.2020.09.013

Affiliations: 12

Authors: 22

Go to article
Institutions Share
Center for Regenerative Medicine (CReM), BU, United States of America (USA) 0.30
Pulmonary Center, BU, United States of America (USA) 0.25
Department of Microbiology, BU, United States of America (USA) 0.11
National Emerging Infectious Diseases Laboratories (NEIDL), BU, United States of America (USA) 0.11
Department of Pathology and Laboratory Medicine (BUMC), BU, United States of America (USA) 0.07
Department of Physiology and Biophysics, BU, United States of America (USA) 0.05
Division of Pulmonary and Respiratory Diseases, BCH, United States of America (USA) 0.04
Center of Thrombosis and Haemostasis (CTH), JGU, Germany 0.03
QIMR Berghofer Medical Research Institute, Australia 0.02
Harvard Department of Medicine, United States of America (USA) 0.02
Department of Biochemistry, BU, United States of America (USA) 0.02
Research Center for Immunotherapy (FZI), JGU, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER